etoposide has been researched along with Multiple Endocrine Neoplasia Type 1 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amano, H; Jujoh, T; Kasahara, Y; Kuroda, F; Kurosu, K; Sakao, S; Tada, Y; Takiguchi, Y; Tanabe, N; Tatsumi, K; Yamada, T | 1 |
Faiss, S; Raue, F; Schaaf, L; ScherĂ¼bl, H; Zeitz, M | 1 |
Daly, PA; Goggins, MG; Kelleher, DP; McDonald, GS; O'Byrne, KJ; Weir, DG | 1 |
3 other study(ies) available for etoposide and Multiple Endocrine Neoplasia Type 1
Article | Year |
---|---|
[Case of thymic carcinoid associated with multiple endocrine neoplasia type I treated effectively with chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Cisplatin; Etoposide; Humans; Male; Middle Aged; Multiple Endocrine Neoplasia Type 1; Thymus Neoplasms; Treatment Outcome | 2010 |
[Hereditary neuroendocrine gastroenteropancreatic tumors and multiple endocrine neoplasia type 1].
Topics: Anti-Ulcer Agents; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Catheter Ablation; Cisplatin; Clinical Trials as Topic; Doxorubicin; Etoposide; Gastrinoma; Gastrointestinal Agents; Humans; Insulinoma; Interferon-alpha; Multiple Endocrine Neoplasia Type 1; Neoplasm Metastasis; Octreotide; Omeprazole; Palliative Care; Pancreatectomy; Pancreatic Neoplasms; Prospective Studies; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Somatostatin; Streptozocin; Time Factors; Zollinger-Ellison Syndrome | 2004 |
A metastatic neuroendocrine anaplastic small cell tumor in a patient with multiple endocrine neoplasia type 1 syndrome. Assessment of disease status and response to doxorubicin, cyclophosphamide, etoposide chemotherapy through scintigraphic imaging with 1
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Indium Radioisotopes; Middle Aged; Multiple Endocrine Neoplasia Type 1; Radionuclide Imaging; Salvage Therapy; Somatostatin | 1994 |